Atlas Trials

EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan

Clinical trial NCT01756261 · COMPLETED

Trial details

NCT number
NCT01756261
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Macular Degeneration
Start date
2012-12-26
Primary completion
2016-07-20
Enrollment
757

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.